all posts

The GiACTA trial: Tocilizumab in giant cell arteritis

Stone et al. Trial of Tocilizumab in Giant-Cell Arteritis. N ...

Happy 4th anniversary!

Today is my anniversary!  The fourth anniversary of my diagnosis.  ...
vasculitis-anca-workshop-announcement
The MIRRA trial: Mepolizumab (Nucala) or placebo for the treatment of EGPA/Churg-Strauss Syndrome

The MIRRA trial: Mepolizumab (Nucala) or placebo for the treatment of EGPA/Churg-Strauss Syndrome

Wechsler et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with ...
How do the IL-5 inhibitors Cinqair, Fasenra, and Nucala work?

How do the IL-5 inhibitors Cinqair, Fasenra, and Nucala work?

The IL-5 inhibitors Cinqair (reslizumab), Fasenra (benralizumab), and Nucala (mepolizumab) ...
Living with #raredisease EGPA: Eosinophilic Granulomatosis with Polyangiitis

Step one: My diagnosis with EGPA/Churg-Strauss vasculitis

Finally!  A diagnosis!  Then you realize that getting the diagnosis ...
Step one: My diagnosis with EGPA/Churg-Strauss vasculitis

Managing vasculitis: A patient’s perspective

Webinar recorded for the March 2017 - Vasculitis Foundation Road ...